WorkspaceResearch
GLAXOPHARMACEUTICALSAlpha Score••Free accountSep-26

GlaxoSmithKline Pakistan Ltd

Shariah compliant
Last close
Rs335.12
+0.60%
3 monthsAs of 19 Nov
BusinessStrongGrowthGrewlast yearValueCore planHealthStrongDividendPatchy

Almost no debt, a strong business, the price in an uptrend and analysts seeing upside. No read is against it.

Working

  • 1 analysts' average target Rs 510, 52% above the price.
  • Debt is 1% of equity in the latest quarter.
  • Revenue up 17% on the same quarter last year.

To watch

  • Raised last year, from Rs 10.00 to Rs 17.00.
Full analysis · free account

Keep reading GLAXO: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, GLAXO's sales rose 17% to Rs 16.6bn, from Rs 14.2bn, and profit after tax rose 28% to Rs 2.6bn, from Rs 2.0bn (compared with Jul–Sep 2025).

Earnings per share were Rs 8.20, against Rs 6.40 a year earlier.

At Rs 335.12, GLAXO trades at 10.4 times earnings, with a dividend yield of 5.7%.

P/E ratio
10.4
Dividend yield
5.7%
Dividend payout
0%
of earnings
Return on equity
32%
Net margin
16.0%
last 12 months
Debt to equity
0.01

GLAXO quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 16.6bnRs 2.6bn15.7%Rs 8.20—
Apr–Jun 2026Rs 14.5bnRs 2.0bn13.6%Rs 6.19Rs 7.00
Jan–Mar 2026Rs 17.0bnRs 2.6bn15.3%Rs 8.20—
Oct–Dec 2025Rs 21.4bnRs 3.8bn17.7%Rs 11.90Rs 12.00
Jul–Sep 2025Rs 14.2bnRs 2.0bn14.4%Rs 6.40—
Apr–Jun 2025Rs 14.7bnRs 2.1bn14.1%Rs 6.50Rs 5.00
Jan–Mar 2025Rs 15.6bnRs 2.1bn13.7%Rs 6.68—
Oct–Dec 2024Rs 17.6bnRs 3.0bn16.8%Rs 9.27Rs 10.00

GLAXO annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Dec 2025Rs 65.9bnRs 10.0bnRs 31.48Rs 17.00
Year to Dec 2024Rs 61.2bnRs 6.5bnRs 20.52Rs 10.00
Year to Dec 2023Rs 49.7bnRs 534.0mnRs 1.68—
Year to Dec 2022Rs 41.8bnRs 2.5bnRs 7.73—
Year to Dec 2021Rs 36.7bnRs 5.4bnRs 16.81Rs 7.00

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 53.8bn
Shareholders' equity
Rs 34.8bn
Cash & bank
Rs 8.1bn
Total debt
Rs 338.0mn
Current ratio
2.20
3-month high
Rs 360.14
3-month low
Rs 300.07
1-month change
+6.4%
3-month change
-3.1%

Read more about GLAXO

Other pharmaceuticals companies

GLAXO: common questions

What is GLAXO's share price?

GlaxoSmithKline Pakistan Ltd (GLAXO) last closed at Rs 335.12 on the Pakistan Stock Exchange.

Does GLAXO pay a dividend?

Yes. GlaxoSmithKline Pakistan Ltd paid Rs 17.00 per share for the year to Dec 2025, and the stock's dividend yield is 5.7%.

What were GLAXO's latest results?

In the Jul–Sep 2026 quarter, GLAXO's sales rose 17% to Rs 16.6bn, from Rs 14.2bn, and profit after tax rose 28% to Rs 2.6bn, from Rs 2.0bn (compared with Jul–Sep 2025).

What is GLAXO's P/E ratio?

At Rs 335.12, GLAXO trades at 10.4 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.